Autonomous At Home with Occupational Therapy Support and Assistive Devices
AUDACE
Autonome À Domicile Grâce À Un Appareil Connecté Et À Un Suivi Ergo
1 other identifier
interventional
3,900
1 country
1
Brief Summary
The aim of the AUDACE study is to evaluate the 'Bien chez Moi 2.0' programme, to assess how, for whom and why do assistive devices, integrated with occupational therapy support, enable older people to remain at home, and under what conditions? The study assesses the impact on areas such as the degree of autonomy, the extent to which life goals are taken into account, the feeling of security at home, the use of hospital emergency services and the postponement of definitive institutionalisation in a nursing home. The expected results of this study are to be able to robustly describe the impact of the 'Bien chez moi 2.0' programme in the areas listed above.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 4, 2024
CompletedFirst Submitted
Initial submission to the registry
January 28, 2025
CompletedFirst Posted
Study publicly available on registry
February 11, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 4, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 4, 2025
CompletedFebruary 11, 2025
January 1, 2025
1.5 years
January 28, 2025
February 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
COPM
Endpoints will be calculated as the within-subject difference in measurement between baseline and six-month follow-up in Canadian Occupational Performance Measure (COPM), assessing daily occupations of importance that people are unable to perform. Scale description: Canadian Occupational Performance Measure Range 1-10 Higher score = Better outcome
At enrolment and six months follow up.
Secondary Outcomes (7)
Short FES-I
At enrolment and six months follow up.
Health-related QoL
At enrolment and six months follow up.
Hospitalisation
At enrolment and six months follow up.
Use of assistive devices
At enrolment and six months follow up.
Sense of security
At enrolment and six months follow up.
- +2 more secondary outcomes
Study Arms (1)
BCM2.0
EXPERIMENTALThe BCM2.0 programme provides occupational therapy sessions and assistive devices to support older people who want to age in place.
Interventions
The BCM2.0 programme provides occupational therapy sessions and assistive devices to support older people who want to age in place.
Eligibility Criteria
You may qualify if:
- people aged 65 and over
- living at home in the Walloon and Brussels regions
- who are considered frail or at risk of frailty. The risk of frailty is defined as having at least one loss of intrinsic capacity measured by a trained occupational therapist using the ICOPE screening tool
You may not qualify if:
- People benefiting from other AViQ autonomy programmes of this project are excluded
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ergo2.0
Yvoir, B-5530, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 28, 2025
First Posted
February 11, 2025
Study Start
March 4, 2024
Primary Completion
September 4, 2025
Study Completion
September 4, 2025
Last Updated
February 11, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- IPD will be shared after the complete study data has been collected and anonymised (expected data: january 2026). This data will remain available on dataverse.uclouvain.be with no end date. ICF and study protocol will be published in a scientific journal. This data will remain available on the journal website with no end date.
IPD will be shared for all collected data. Pseudonymised individual study data will undergo an anonymisation process with the help of an expert in data anonymity to ensure that no combination of data would allow re-identification of participants. The data will be publicly available on UCLouvain's public open data repository http://dataverse.uclouvain.be/.